organization · Reporting owner
Ares Trading S.A.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vera Therapeutics, Inc.VERA · Entity 4358 | 10% owner | May 13, 2021 | May 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vera Therapeutics, Inc.
Report date May 13, 2021 · Filed May 14, 2021
Jointly reported with Merck KGaA, MERCK SERONO S.A.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series C Preferred StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-05-13 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The Series C Preferred Stock is convertible into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and has no expiration date. Upon filing of the Issuer's Restated Certificate of Incorporation in connection with the Issuer's initial public offering, all shares of Series C Preferred Stock will be converted into shares of Class A Common Stock of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series C Preferred Stock is convertible into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and has no expiration date. Upon filing of the Issuer's Restated Certificate of Incorporation in connection with the Issuer's initial public offering, all shares of Series C Preferred Stock will be converted into shares of Class A Common Stock of the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PRECIGEN, INC.
Report date October 12, 2021 · Filed October 14, 2021
Section 16 reporting ended · disclosed 2021-10-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,647,152 |
Ending reported balance
After 2021-10-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-10-12 · Sale · Disposed 63,900 · Balance 20,727,048 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021.The plan was terminated effective October 13, 2021. Row 2 · 2021-10-13 · Sale · Disposed 79,896 · Balance 20,647,152 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021.The plan was terminated effective October 13, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021.The plan was terminated effective October 13, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2021 Filed May 26, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 62,469 | $6.57 | $410,552.51 |
DisclosureSEC source: 0001104659-21-072540 · tm2117610-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,412,066 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 21, 2021 Filed May 24, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 131,409 | $6.86 | $901,005.81 |
DisclosureSEC source: 0001104659-21-071379 · tm2117379-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,474,535 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 149,648 | $6.61 | $988,739.30 |
DisclosureSEC source: 0001104659-21-071379 · tm2117379-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,605,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 19, 2021 Filed May 20, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 121,500 | $6.50 | $789,628.50 |
DisclosureSEC source: 0001104659-21-070037 · tm2117068-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,755,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 134,043 | $6.85 | $918,569.87 |
DisclosureSEC source: 0001104659-21-070037 · tm2117068-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,877,092 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 17, 2021 Filed May 18, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 79,355 | $6.75 | $535,987.48 |
DisclosureSEC source: 0001104659-21-068959 · tm2116824-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,011,135 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 14, 2021 Filed May 18, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 185,360 | $6.71 | $1,244,303.14 |
DisclosureSEC source: 0001104659-21-068959 · tm2116824-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,090,490 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 13, 2021 Filed May 14, 2021 22:02 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 122,389 | $6.52 | $798,184.34 |
DisclosureSEC source: 0001104659-21-067029 · tm2116441-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,275,850 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 12, 2021 Filed May 14, 2021 22:02 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 150,000 | $7.00 | $1,050,510.00 |
DisclosureSEC source: 0001104659-21-067029 · tm2116441-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,398,239 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 151,164 | $6.40 | $966,935.64 |
DisclosureSEC source: 0001104659-21-065257 · tm2116044-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,548,239 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 10, 2021 Filed May 12, 2021 22:00 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 114,603 | $6.34 | $726,743.46 |
DisclosureSEC source: 0001104659-21-065257 · tm2116044-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,699,403 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 07, 2021 Filed May 10, 2021 22:01 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 150,000 | $6.55 | $982,485.00 |
DisclosureSEC source: 0001104659-21-064061 · tm2115723-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,814,006 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:01 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 100,000 | $6.54 | $653,850.00 |
DisclosureSEC source: 0001104659-21-064061 · tm2115723-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,964,006 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 05, 2021 Filed May 6, 2021 23:10 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 57,261 | $6.86 | $392,638.68 |
DisclosureSEC source: 0001104659-21-062586 · tm2115405-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,064,006 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 04, 2021 Filed May 6, 2021 23:10 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 94,950 | $7.08 | $672,236.51 |
DisclosureSEC source: 0001104659-21-062586 · tm2115405-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,121,267 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:01 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 74,172 | $7.47 | $553,990.67 |
DisclosureSEC source: 0001104659-21-061148 · tm2115104-1_4seq1.xml · nonDerivative · entry 2 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,216,217 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| April 30, 2021 Filed May 4, 2021 22:01 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 108,130 | $7.90 | $853,740.42 |
DisclosureSEC source: 0001104659-21-061148 · tm2115104-1_4seq1.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,290,389 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 12:09 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 6,758,400 | $3.70 | $24,999,997.44 |
DisclosureSEC source: 0001104659-20-113680 · tm2032775-1_4.xml · nonDerivative · entry 1 Ares Trading S.A. · CIK 0001720283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,398,519 F1 · kind: On October 7, 2020, Ares Trading S.A. converted all of the $25,000,000 outstanding principal amount of the Convertible Note issued to Ares Trading S.A. (as described in Footnote (1) to the Form 3 filed by the reporting persons on January 22, 2019) into 6,758,400 shares of Common Stock of the Issuer at a conversion price of $3.6991 per share, reflecting the volume weighted-average price per share of the Common Stock on the Nasdaq Stock Market for the consecutive ten trading days immediately prior to the conversion date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.